Test Directory
Anticardiolipin Antibody (IgG, IgM, IgA)
Justification
Anticardiolipin (ACL) antibodies are associated with antiphospholipid syndrome (APS). Persistently elevated levels of ACL antibodies are associated with an increased risk of vascular thrombosis and obstetrical complications.
STAT: < 48 hours (M-F)
CIA
Draw Tube: Red Top
Sample Type: Serum
Specimen Requirements
Sample Type | Volume Required | Minimum Volume | Stability | |
---|---|---|---|---|
PREFERRED | Serum | 1mL | 0.5mL | Room Temp.: 7 days
Refrigerated: 14 days Frozen (-20C): 1 month Frozen (-80C): 6 months |
ALTERNATIVE | Citrated Plasma | 1mL | - | Frozen (-20C): 1 month
Frozen (-80C): 6 months |
REJECTION CRITERIA | Thawed in transit, refrozen or clotted sample |
SPECIAL INSTRUCTIONS | - |
General Information
METHODOLOGY | CIA |
STAT TAT | < 48 hours (M-F) |
STAT TAT Performance | > 90% of results released in 48 hours |
ROUTINE TAT | < 3 days (M-F) |
ALTERNATIVE NAMES | ACL, cardiolipin antibodies |
DESCRIPTION | This assay employs an FDA-approved, chemiluminescent immunoassay (CIA) method and reports in arbitrary chemiluminescent units (CU). |
LIMITATIONS | - |
NORMAL RANGE | < 20 CU |
ASSOCIATED TESTING | - |
REFERENCES | 1. Miyakis et al. International consensus statements on an update of the classification criteria for definite APS. J Thromb Haemost 2006, 4:295-306. |
SAMPLE REPORT | Upon request |
NEW YORK STATE APPROVED | - |
Test Codes
ORDER CODE | P3027 |
CPT CODE | 86147x3 |
LOINC CODE | 3181-5, 3182-3, 5076-5 |